Primary objective: To examine the short-term effects of of simvastatin on the vision on males with choroideremia, evaluated by full-field scotopic threshold testing. The investigators hypothesize that they will see a reversible decrease in the dark-adapted vision in participants taking simvastatin.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
2
Simvastatin 40mg daily by mouth for 5 weeks (4-6 week window) followed by 5 week washout period (4-6 week window).
Ophthalmology Research Office, University of Alberta
Edmonton, Alberta, Canada
Full-field scotopic threshold
Full-field scotopic threshold measured at 4-6 weeks after simvastatin administration.
Time frame: 5 weeks (4-6 weeks)
Microperimetry, OCT, fundus autofluorescence, ERG, VA
Correlation of retinal structure and function with changes in FST after administration of simvastatin.
Time frame: 5 weeks (4-6 weeks)
Microperimetry, OCT, fundus autofluorescence, ERG, VA
Correlation of retinal structure and function with changes in FST after washout of simvastatin.
Time frame: 5 weeks (4-6 weeks)
Full-field scotopic threshold
Full-field scotopic threshold after washout of simvastatin.
Time frame: 5 weeks (4-6 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.